Antitrust Implications of Four Financial Red Flags in the PSKY-WBD Merger
A few weeks ago, we identified four financial red flags, and Paramount…
Unilever-McCormick $44 Bn Deal: Antitrust and Financial Analysis
On 31 March 2026, McCormick & Company and Unilever announced a definitive…
Prosus Sale of 10% Delivery Hero Stake to Aspex Hides a Power Shift and a Legal Risk
Dutch technology investor Prosus is reportedly considering selling part of its shareholding…
The Deutsche Börse-Allfunds Remedy Plan: Openness, Data Neutrality, and Euroclear
Deutsche Börse is playing the Savings and Investments Union (SIU) card to…
Airbus-Thales-Leonardo Need OHB, SES, and Indra’s Nods To Clear JV
The race to create a European "Space Champion" is about to enter…
Paramount-WBD: Financial and Antitrust Analysis
Paramount’s executives expect a relatively easy regulatory review, with a closing within…
Europe Holds All the Cards in the Paramount-WBD Merger
As the route for Paramount's $111 billion bid for Warner Bros. Discovery…
ADNOC-Covestro and the Art of FSR Negotiation: Trading Subsidized Capital for a Green Remedy
In November 2025, the European Commission approved ADNOC’s acquisition of Covestro under…
Symrise Climbs 8% Following DOJ Probe Closure and Industry Cycle Shift
Symrise shares surged nearly 8% yesterday following news that the U.S. Department…
Alphabet’s AI Integration Strategy Outpaces Regulatory Headwinds
Oops! They did it again. Alphabet’s Q4 2025 and FY results exceeded…
Deutsche Börse-Allfunds €5.3B Deal is a Phase II Candidate With Remedies in Sight
On January 21, 2026, Deutsche Börse Group (DBG) and Allfunds Group plc…
